Parse Wins Ruling Voiding Roche-Licensed DNA Sequencing Patent

Parse Biosciences Inc. convinced a federal judge to invalidate one of four patents covering single-cell sequencing technology that Roche Holding AG licensed to Scale Biosciences Inc., narrowing the infringement case ahead of a jury trial later this month.

ScaleBio’s US Patent No. 11,634,752 doesn’t adequately describe the invention or teach skilled scientists how to make or use it, Magistrate Judge Christopher J. Burke wrote in an opinion issued Wednesday in the US District Court for the District of Delaware. A jury trial is set to begin Oct. 20.

Burke said the patent’s dependent claims expanded the independent claim’s scope to ...